Skip to main content
. 2017 May 16;317(19):1967–1975. doi: 10.1001/jama.2017.5283

Table 1. Participant Characteristics at Baseline.

Mean (SD)
Triamcinolone
(n = 70)
Saline
(n = 70)
Age, y 59.1 (8.3) 57.2 (7.6)
Women, No. (%) 37 (52.9) 38 (54.3)
White, No. (%) 47 (67.1) 42 (60.0)
BMI 30.8 (5.1) 31.7 (6.6)
Varus or valgus malalignment, No. (%) 53 (75.7) 55 (78.6)
Synovial pouch depth, mm 4.2 (1.9) 4.5 (2.0)
KL score, No. (%)
2 29 (41.4) 29 (41.4)
3 41 (58.6) 41 (58.6)
Clinical
VAS pain scorea 38.4 (22.2) 42.6 (22.1)
WOMAC scoreb
Pain 8.2 (3.0) 8.4 (3.0)
Function 28.3 (10.8) 30.1 (9.5)
Stiffness 3.7 (1.6) 4.0 (1.4)
20-m Walk, s 19.8 (6.7) 18.2 (3.8)
Chair stand, s 18.3 (8.6) 17.2 (6.5)
SF-36 scorec
Physical 36.7 (9.1) 35.4 (9.7)
Mental 52.6 (10.2) 52.2 (10.0)
Hemoglobin A1c, mean (SD), % 6.0 (0.8) 6.0 (0.6)
C-reactive protein, mean (SD), mg/L (log) 0.6 (1.2) 0.4 (1.1)

Abbreviations: BMI, body mass index, calculated as weight in kilograms divided by height in meters squared; KL, Kellgren-Lawrence; VAS, visual analog scale; WOMAC, Western Ontario and McMaster Universities.

a

Values range from 0 to 100, for which 0 indicates no pain and 100, extreme pain.

b

Scores for WOMAC are defined in the Methods section.

c

The 36-Item Short Form Health Survey (SF-36) scores range from 0 to 100, with higher scores representing better health status.